-
Jul 22, 2024, 4:25 pm196 ptsTop
Green Market Report
Johnson & Johnson (NYSE: JNJ) has asked U.S. regulators to approve its nasal spray Spravato as a standalone treatment for adults with treatment-resistant depression, the company announced Monday. The pharmaceutical giant is seeking to expand the use of Spravato, which is currently approved only in combination…
Trending Today on NewsBudz
NewsBudz is a marijuana and medical cannabis news app. The site delivers a daily feed of the latest cannabis news. We aggregate over 30 of the web's best sources for news about marijuana, hemp and legalization to keep you informed.
Stay on top of the latest news headlines, trends and developments worldwide around recreational and medical marijuana. Sit back and relax, while you read learn and share. On the web or your mobile device, NewsBudz is your cannabis news stream.
